Bexlosteride (LY300502), a benzoquinolinone derivative, functions as a human type I 5alpha-reductase inhibitor. It demonstrates metabolic inhibition, antiproliferative, and antisecretory activities specifically in LNCaP human prostatic adenocarcinoma cell cultures, positioning it as a potent agent for prostate cancer research [1] [2].
Molecular Weight:
249.74
CAS Number:
[148905-78-6]
Formula:
C14H16ClNO
Target:
Others
T9660
* VAT and and shipping costs not included. Errors and price changes excepted
